The Endocannabinoid Anandamide Protects Neurons during CNS Inflammation by Induction of MKP-1 in Microglial Cells

Translating the Histone Code

Jenuwein, T., & Allis, C. D. (2001) · Science · doi:10.1126/science.1063127 · Cited by 9,756

Molecular characterization of a peripheral receptor for cannabinoids

Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092

Axonal transection in the lesions of multiple sclerosis

Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., & Bö, L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380502 · Cited by 4,029

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913

Determination and characterization of a cannabinoid receptor in rat brain

Devane, W. A., Dysarz, F. A., Johnson, M. R., Melvin, L. S., & Howlett, A. C. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09876-1 · Cited by 2,443

Cannabinoid receptor localization in brain.

Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1932 · Cited by 2,321

2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain

Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., & Waku, K. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2437 · Cited by 2,196

The molecular logic of endocannabinoid signalling

Piomelli, D. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1247 · Cited by 1,957

Expression of Central and Peripheral Cannabinoid Receptors in Human Immune Tissues and Leukocyte Subpopulations

Galiègue, S., Mary, S., Marchand, J., Dussossoy, D., Carrière, D., Carayon, P., Bouaboula, M., Shire, D. J., Fur, G. L., & Casellas, P. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.tb20780.x · Cited by 1,776

Formation and inactivation of endogenous cannabinoid anandamide in central neurons

Marzo, V. D., Fontana, A., Cadas, H., Schinelli, S., Cimino, G., Schwartz, J.-C., & Piomelli, D. (1994) · Nature · doi:10.1038/372686a0 · Cited by 1,585

The endocannabinoid system : a translational study from Achilles tendinosis to cyclooxygenase

Björklund, E. (2014) · KTH Publication Database DiVA (KTH Royal Institute of Technology)

Angefertigt mit Genehmigung der Mathematisch-Naturwissenschaftlichen Fakultät der

Bonn, R. F.-W.-U. (2012)

Endocannabinoid system modulation of the ocular immune response

Toguri, J. T. (2015) · DalSpace (Dalhousie University)

Mechanisms underlying the neuroprotective effects of histone deacetylase inhibitors

Durham, B. S. (2015) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)

Anandamide Modulation of Endotoxin-Induced Inflammation

Henry, D. M. K. R. (2013) · Anatomy & Physiology · doi:10.4172/2161-0940.1000e130

Emerging Oral Medications for Multiple Sclerosis

Fredrikson, S., & Hillert, J. A. (2012) · doi:10.2217/9781780840482

Alterations in JAK/STAT signaling pathway and blood-brain barrier function: Mechanisms underlying worsened outcome following stroke in the aged rat.

DiNapoli, V. A. (2008) · doi:10.33915/etd.8760

SFB TRR43: Das Gehirn als Ziel von entzündlichen Prozessen

Heppner, F. L., & Zipp, F. (2008) · e-Neuroforum · doi:10.1515/nf-2008-0308

Therapeutic Mechanisms for Cannabinoid-Promoted Survival of Oligodendrocytes

Ribeiro, R. B. (2013)

O potencial terapêutico de compostos canabinoides em um modelo in vitro de morte neuronal.

Vrechi, T. A. D. M. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.42.2016.tde-11082016-090204

Potential drug targets for oral medications

Luessi, F., & Zipp, F. (2012) · doi:10.2217/ebo.12.32

Commentary on interactions between neurotropic pathogens, neuroinflammatory pathways, and autophagic neural cell death

Cellina, M. I., & Orsi, M. (2018) · Neuroimmunology and Neuroinflammation · doi:10.20517/2347-8659.2018.15

Efeito do agonista seletivo do receptor canabinoide 1 (CB1) em modelos de neurodegeneração induzida pela estreptozotocina.

Crunfli, F. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2018.tde-14032018-110624

The role of p38 mitogen-activated protein kinase in corticosteroid-insensitivity in severe asthma and COPD

Khorasani, N. M. (2015) · Spiral (Imperial College London) · doi:10.25560/52433

Virtual Screening and Biochemical Evaluation to Identify the Allosteric Inhibitors of Dual Specificity Phosphatase 1

Park, H., Kim, M., Park, T. H., Jeon, T. J., Chun, H., & Ryu, S. E. (2019) · Bulletin of the Korean Chemical Society · doi:10.1002/bkcs.11670

Natural molecules as epigenetic modifiers in reproduction

Natarajan, L., & Saldanha, S. N. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819753-0.00018-0

Cannabinoid Receptor and InflammationPreprint

Osafo, N., Yeboah, K. O., Antwi, A. O., & Ainooson, G. K. (2020) · doi:10.22541/au.159986420.00633539 · Cited by 1

Papel de Endocanabinoides na modulação de células-tronco de Papila Apical in vitro

Meneses, C. C. B. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.23.2020.tde-24022021-154422

Investigation of the endocannabinoid system using in vivo and in vitro models

Ternes, S. (2013) · bonndoc (University of Bonn)

Targeting Acute Inflammation

Luessi, F. (2021) · Neuromethods · doi:10.1007/978-1-0716-1213-2_18

Faculty Opinions recommendation of Anti-inflammatory lipoxin A4 is an endogenous allosteric enhancer of CB1 cannabinoid receptor.

Pertwee, R. G. (2012) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.717967813.793467396

Physical Exercise Improved P2Y12-Regulated Microglial Dynamics and Protected Against Ischemic Stroke in the Brain via Endocannabinoid SignalingPreprint

He, X., Zhao, Y., Li, G., Luo, J., Xu, J., Zheng, H., Zhang, L., & Hu, X. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4072048

Endogenous Mediators of Neuroinflammation: The Endocannabinoid System at the Retina

Duraikkannu, D., & Chatterjee, N. (2022) · Springer eBooks · doi:10.1007/978-981-16-8313-8_25

Therapeutic implications of the endocannabinoid system in neurodegenerative diseases

Goren, A., & University of Rome "G.Marconi" (2015) · Clinical Case Reports and Reviews · doi:10.15761/ccrr.1000126

Exercise Improved P2Y12-Regulated Microglial Dynamics During Stroke Via Endocannabinoid SignalingPreprint

He, X., Zhao, Y., Li, G., Luo, J., Xu, J., Zheng, H., Zhang, L., & Hu, X. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.24.538065

ТЕРАПЕВТИЧЕСКИЕ ЭФФЕКТЫ КАННАБИНОИДОВ ПРИ ПАТОЛОГИИ ЦЕНТРАЛЬНОЙ НЕРВНОЙ СИСТЕМЫ (ОБЗОР ЛИТЕРАТУРЫ)

Колесников, А. Н., Гридасова, Е. И., & Абрамова, Е. А. (2023) · Military and tactical medicine Emergency medicine · doi:10.55359/2782-3296.2023.90.22.013

Conclusion

Leweke, F. M., & Rohleder, C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-19081-0.00020-2

Anandamide: From modulation of neuronal excitation to antimicrobial activities—What is in common?

Sionov, R. V., & Steinberg, D. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-19081-0.00017-2

Epigenetic modulation by the endocannabinoid system in the central nervous system

Pereira-Teixeira, C., Pereira, F. C., Carvalho, F., & Silva, J. P. (2025) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-443-13908-6.00015-3

Cannabinoids for the Control of multiple Sclerosis

Pryce, G., Jackson, S., & Baker, D. (2007) · Springer eBooks · doi:10.1007/978-0-387-74349-3_18

FIGURES 45. Axinyssa djiferi spec. nov. 4 in A new species of Axinyssa Lendenfeld, 1897 (Porifera, Demospongiae, Halichondrida) from the Senegalese coast

Boury‐Esnault, N., Marschal, C., Probst, J.-M. K., & Barnathan, G. (2002) · INFM-OAR (INFN Catania) · doi:10.5281/zenodo.155630

Etudes de trois métalloprotéases matricielles, MT1-MMP, MT5-MMP et MMP-12 dans l'amyloïdogenèse et les atteintes inflammatoires et vasculaires associées à la maladie d'Alzheimer

Bonnet, A. (2017) · theses.fr (ABES) · doi:10.70675/7fa1337ez8c86z4faezb643z1ee618bb3cfa

Endocannabinoid system, inflammation, and mental well-being

Iqbal, A. Z., Wu, S., Yaseen, M., Suwindi, P. M., Chang, J. P., & Su, K. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-28842-5.00023-5

Anti-inflammatory effects of single cannabinoids and in combinationsPreprint

Mikkelsen, J. D., Prösser, L. A., Sørensen, H. K., Nabizada, E., Ortega, R. N. G., Ujhelyi, A., Okeyo, P. O., Breum, J., Rose, M., & Allesø, M. (2026) · Research Square · doi:10.21203/rs.3.rs-9759455/v1

Tocotrienol metabolites redirect lipid mediator production in innate immune cells towards inflammation resolution

Permann, S., Brunner, E., Alsabil, K., Werner, M., Waltl, L., Viault, G., D’Avino, D., Perkowski, B. J., Siller, A., Fritsch, L., et al. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.06.056

Serum metabolomics modelling reveals stage-associated purine and endocannabinoid metabolic signatures in colorectal cancer progression

Klekowski, J., Fortuna, P., Chabowski, M., Lewandowski, Ł., Szewczak, W., Mosna, K., Maciejewska, G., Zawadzki, M., Krzystek‐Korpacka, M., & Fleszar, M. G. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1900337

Preclinical evidence of neuroprotective effects of endocannabinoids and related lipid molecules in ischemic stroke: a systematic review and meta-analysis of animal studies

Li, X., Wen, L., Du, Y., Zhou, J., Xue, N., Fan, X., Zhao, H., & Qu, M. (2026) · European journal of medical research · doi:10.1186/s40001-026-04990-w

Selective CB2 receptor activation attenuates neuroinflammation and preserves immune responsiveness after photothrombotic stroke

Bietar, B., Tanner, S., Abdolmohammadi, P., Kasheke, G. D. S., Zhou, J., & Lehmann, C. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.117539

BindingDB Entry 50019509: Development of potent and selective FAAH inhibitors with improved drug-like properties as potential tools to treat neuroinflammatory conditions.

BindingDB (2024) · UC San Diego · doi:10.7270/q2t43zf0

BindingDB Entry 50038657: Discovery and optimization of a novel series of N-arylamide oxadiazoles as potent, highly selective and orally bioavailable cannabinoid receptor 2 (CB2) agonists.

BindingDB (2012) · UC San Diego · doi:10.7270/q2w096vs

Endocannabinoid regulation of microglia–astrocyte crosstalk in Alzheimer’s disease

Rao, J. S., Tangarife, M. A., Rodríguez‐Soacha, D. A., & Mukunda, R. (2026) · Academia Drug Development and Pharmacotherapy · doi:10.20935/acaddrug8564

Cannabinoids in the Brain: Their Metabolism, Roles, and Involvement in Neurological Disorders

Farooqui, A. A. (2011) · Springer eBooks · doi:10.1007/978-1-4419-9940-5_5

Cannabinoids for the control of experimental multiple sclerosis

Pryce, G. (2010) · OpenGrey (Institut de l'Information Scientifique et Technique)

THE ROLE OF CANNABINOIDS AND CANNABINOID RECEPTORS IN ENTERIC NEURONAL SURVIVAL

Li, Y. (2009) · VCU Scholars Compass (Virginia Commonwealth University) · doi:10.25772/rszw-w547

Investigating the role of mitogen activated protein kinase phosphatase-2 on CNS function

Rahman, N. Z. A. (2015) · STAX · doi:10.48730/t2m5-nd82

PRECLINICAL DEVELOPMENT OF PHYTOCANNABINOID- AND ENDOCANNABINOID- BASED PHARMACOTHERAPIES FOR THE TREATMENT OF ETHANOL-INDUCED NEURODEGENERATION

Liput, D. J. (2013) · UKnowledge (University of Kentucky)

Cannabinoids in Microglia: A New Trick for Immune Surveillance and Neuroprotection

Rivest, S. (2006) · Neuron · doi:10.1016/j.neuron.2005.12.004 · Cited by 26

Endocannabinoids regulate the activity of astrocytic hemichannels and the microglial response against an injury: In vivo studies

Vázquez, C., Tolón, R. M., Pazos, M. R., Moreno, M., Koester, E. C., Cravatt, B. F., Hillard, C. J., & Romero, J. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.04.005 · Cited by 42

CD200‐CD200R1 interaction contributes to neuroprotective effects of anandamide on experimentally induced inflammation

Hernangómez, M., Mestre, L., Correa, F., Loría, F., Mecha, M., Iñigo, P. M., Docagne, F., Williams, R. O., Borrell, J. I., & Guaza, C. (2012) · Glia · doi:10.1002/glia.22366 · Cited by 130

Neuroprotective effect of endogenous cannabinoids on ischemic brain injury induced by the excess microglia-mediated inflammation.

Guo, S., Liu, Y., Ma, R., Li, J., & Su, B. (2016) · Europe PMC (PubMed Central) · Cited by 11

P.3.f.002 CNS infections during childhood and risk for schizophrenia: a case control study

Halperin, D. S., Davidson, M., Werbeloff, N., Yoffe, R., Levine, A., Livni, G., & Weiser, M. (2008) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(08)70707-7